Edward Grahame | Alliance Manager - Nanomedicine Services
Cytiva

Edward Grahame, Alliance Manager - Nanomedicine Services, Cytiva

I am the Nanomedicine Alliance Manager for Europe with Cytiva, my role is focused on advancing Cytiva’s LNP-platform and drug-development services with drug developers in Europe.  I leverage over 10 years’ experience in nanomedicine vaccine development.  I completed my PhD in 2016 from the University of Glasgow on the improvement of bacterial vaccines for respiratory pathogens.  After completing my PhD, I worked for several years for a biotherapeutic start-up company developing nanomedicine treatments for various respiratory diseases, my role concerned advancement of the company’s formulation design, CMC activities and pre-clinical testing.  At the onset of the COVID-19 pandemic, I took up a position with Cytiva on the development of their saRNA-LNP vaccine programme and since 2022 I have been assisting our customers in Europe access our LNP technologies for advancement of their therapeutics.

Appearances:



Day 1 - Tuesday 14th October @ 14:30

Scaling new heights: ionizable lipids for vaccine development, GMP manufacturing, and clinical success

Session led by: cytiva
last published: 02/Jul/25 11:15 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK

 

Isla Sutherland
Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.